Montgomery Community Media

Gaithersburg based MedImmune, the global biologics research and development arm of AstraZeneca, announced Nov. 14 that Yong-Jun Liu, M.D., Ph.D. has been named the company’s new head of research, effective Jan. 6, 2014. Dr. Liu currently serves as vice president and chief scientific officer at the Baylor Research Institute and director of the Baylor Institute […]

AstraZeneca announced (Oct. 30) the start of the Phase III Windward programme for benralizumab, a potential treatment for severe uncontrolled asthma developed by MedImmune, the company’s global biologics research and development arm. The goal of CALIMA, the first study in the Windward programme, is to determine whether benralizumab reduces the number of exacerbations in patients […]

MedImmune, completed its acquisition of Amplimmune, a privately-held, Gaithersburg based biologics company focused on developing novel therapeutics in cancer immunology. MedImmune acquired 100% of Amplimmune’s shares for an initial consideration of $225 million and deferred consideration of up to $275 million based on reaching established development milestones. Founded in 2007 and headquartered in Gaithersburg, Amplimmune […]

MedImmune, AstraZeneca’s global biologics research and development arm, and the University of Maryland, Baltimore (UMB) have announced they have entered into a five-year, $6 million collaboration to drive novel bioscience research in the state of Maryland. This agreement represents the first of several planned innovative collaborations by MedImmune to actively work with leading regional research […]

MedImmune, AstraZeneca’s global biologics research and development arm, will celebrate its 25th anniversary this week, recognizing a robust history of innovation in the biotech industry. As one of the largest biotech companies in Maryland, MedImmune employs almost 2,000 people at its Gaithersburg headquarters and is a significant contributor to the local economy and emerging life […]

AstraZeneca has announced that MedImmune, its global biologics research and development arm, has entered into a definitive agreement to acquire Amplimmune, a privately-held biologics company focused on developing novel therapeutics in cancer immunology. The buyout is designed to strengthen MedImmune’s cancer-related research, and includes an initial payment of $225 million, with the possibility of another […]

The MdBio Foundation’s Young Science Explorers Program is a 30-hour summer workshop for rising seventh and eighth graders that recently met at the Germantown campus of Montgomery College. Over the course of one week, the Young Science Explorers participated in a variety of hands on activities that involved the life sciences and bioscience industry in […]

Quince Orchard Park residents in Gaithersburg are being notified that MedImmune is pursuing the rezoning of the property at 101 Orchard Ridge Drive from industrial-3 (I-3) to mixed-use development (MXD). “Our goal with this effort is to have a uniform zoning designation of MXD across our entire campus,” said Liz Huntley, associate director of public […]

Officials gathered to honor some of Montgomery County’s most distinguished volunteers and community servants at the Montgomery Serves Awards Ceremony in Bethesda on April 29. MyMCMedia’s Sonya Burke reports. For more information about voluntering in Montgomery County, visit the www.montgomeryserves.org website.

Montgomery County Executive Isiah Leggett announced the winners of the Montgomery Serves awards, the Neal Potter Path of Achievement awards and the Roscoe R. Nix Distinguished Community Leadership awards today (March 28). A ceremony to present the awards to the nine honorees will take place on Monday, April 29 at the Imagination Stage in Bethesda. […]